Showing results (1851-1860 of 2,777) with videos related to
Sort By:
Pageof 278
Clinical and Experimental Nephrology|November 13, 2013
Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetesAndrzej S Krolewski, Tomohito Gohda, Monika A NiewczasClinical and Experimental Nephrology|November 7, 2014
High renal resistive index in hypertensive patients is also associated with serum homocysteine levelŞakir Özgür Keşkek, Yavuz Çinar, Sinan Kirim, et al.Clinical and Experimental Nephrology|October 30, 2014
Contrast-enhanced ultrasound (CEUS) in nephrology: Has the time come for its widespread use?Antonio Granata, Luca Zanoli, Monica Insalaco, et al.Clinical and Experimental Nephrology|October 30, 2014
Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in JapanEiji Higashihara, Kikuo Nutahara, Takatsugu Okegawa, et al.Clinical and Experimental Nephrology|December 24, 2013
Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trialTakao Saito, Masayuki Iwano, Koichi Matsumoto, et al.Clinical and Experimental Nephrology|March 27, 2026
Discrepancy between cystatin C-based and creatinine-based eGFR predicts all-cause mortality in a community-based population: the Takahata studyTakaya Suzuki, Kazunobu Ichikawa, Natsuko Suzuki, et al.Clinical and Experimental Nephrology|March 24, 2026
Progression of diabetic nephropathy and adverse renal outcomes: possible involvement of Toll-like receptor 4 expressionAyano Saito, Fumito Abe, Masaya Saito, et al.Clinical and Experimental Nephrology|April 15, 2026
Association between serum lactate dehydrogenase level and renal outcome in patients with advanced chronic kidney disease without diabetes mellitusYoshihiro Nakamura, Shimon Kurasawa, Takahiro Imaizumi, et al.Clinical and Experimental Nephrology|April 13, 2026
eGFR slope improvement with SGLT2 inhibitors is not statistically associated with changes in urinary protein in Japanese CKD patients: a single-center real-world analysisShogo Kuwagata, Masami Chin-Kanasaki, Aki Yamada, et al.Clinical and Experimental Nephrology|May 30, 2023
All reported non-canonical splice site variants in GLA cause aberrant splicingEri Okada, Tomoko Horinouchi, Tomohiko Yamamura, et al.Pageof 278